ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach Candidacy for FDA Hampered By Three Republican Holds.

December 1, 2006

Dept. of Defense opens program announcements for prostate cancer research.

December 10, 2004

Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants

April 8, 1977

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011